Documentation Centre

Flash required
March 13, 2013
Do you think abdominal obesity could also become a relevant therapeutic target for the optimal management of CVD risk in patients with type 2 diabetes?
By Peter Libby, MD, Chief, Cardiovascular Medicine, Brigham and Women's Hospital, Mallinckrodt Professor of Medicine, Harvard Medical School, Boston, USA [2:26 min.] [38MB]

  • See all Expert Opinions of Peter Libby, MD, Chief, Cardiovascular Medicine, Brigham and Women's Hospital, Mallinckrodt Professor of Medicine, Harvard Medical School, Boston, USA

Download Video


Key Words
Diabetes, Documentation Centre, Abdominal Obesity/Body Fat Distribution